ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2822

IKKε Deficiency Prolongs Neutrophil Survival Paradoxically Prolonging Inflammation In The Absence Of a Type I Interferon Response

Maripat Corr1, Christopher Chung2, Seong-Kyu Kim3, D. L Boyle4 and G. S. Firestein5, 1Medicine, Univ of California-San Diego, La Jolla, CA, 2Medicine, UCSD School of Medicine, La Jolla, CA, 3Catholic University of Daegu School of Medicine, Daegu, South Korea, 4Div of Rheum, UCSD School of Medicine, La Jolla, CA, 5Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Animal models, Apoptosis, chemokines, interferons and neutrophils

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Deficiency of the IKK-related kinases IKKε synergizes with the anti-inflammatory effects of IFNß in a murine model of arthritis., and this effect is mediated by IL-1Ra. To further explore the relationship between IFN signaling and IKKε, IKKε null mice were intercrossed with IL1Ra or type I interferon receptor deficient mice and evaluated in the passive K/BxN model of arthritis. 

Methods:

IKKε null, Il1rn (which encodes IL-1Ra) null, IL1Ra/IKKε null, IFNAR1 null, IFNAR1/IKKε null and wild type mice were injected with 150 ul of pooled K/BxN sera on day 0. Clinical response and histologic scores were assessed. Gene expression was measured by quantitative PCR. Mice were injected intraperitoneally with thioglycollate. The peritoneal lavage was evaluated for cell counts. The number and viability of neutrophils was determined by flow cytometry. Gene expression and protein production were tested by qPCR and western blot respectively.

Results:

IKKε null mice had a modestly attenuated course of arthritis (area under the curve [AUC] for ankle diameter=5.1 vs. 5.9 for wild type controls, P<0.05). In contrast IFNAR1 null mice (AUC 6.3 vs. 5.9, P<0.05) and Il1rn-/- mice (AUC 11.4 vs. 5.9 P<0.01) had more severe serum transfer arthritis than wild type mice. The IL1Ra/IKKε null had arthritis similar (AUC 12.1) to the Il1rn-/- mice (AUC 11.4). Unexpectedly, IFNAR1/IKKε null mice (AUC 7.9, P<0.05) had even greater disease severity than the IFNAR1 null (AUC 6.3) mice. The ankle histology scores in each strain correlated well with the clinical course. Of interest, quantitative PCR of arthritis paws showed a significant increase in the neutrophil chemotactic protein GCP2 in the IFNAR1 (98+10) and IFNAR1/IKKε (81+11) null compared to the WT (19+1) mice (p<0.05).  There was no difference in IL-6, IL-1ß, IL-1a or IFNb in the IL1Ra/IKKε null or IFNAR1/IKKε null mice compared to the individual knockout controls. Concordant with higher GCP2 expression mice deficient in IFN signaling recruited higher numbers of neutrophils into the peritoneum after thioglycollate challenge: 4.6+1 (WT), 6.1+2 (IKKε), 15.8+4.8 (IFNAR1) and 13.5+2.8 (IFNAR1/IKKe) x106 neutrophils (p<0.05).  The neutrophils recovered from the IFNAR1/IKKε mice, however, expressed higher mRNA and protein levels of the anti-apoptotic protein Mcl1 than those of the individual knockout controls, suggesting that the deficient neutrophils had defective apoptosis.

Conclusion:

IKKε deficiency did not offset increased severity in IL-1Ra deficiency supporting a direct role of IL-1Ra in reducing arthritis. Surprisingly, IKKε deficiency increased disease severity in the IFNAR null mice, most likely due to increased neutrophil recruitment and prolonged survival.


Disclosure:

M. Corr,

NIAMS-NIH,

2,

UCSD,

3;

C. Chung,
None;

S. K. Kim,
None;

D. L. Boyle,

NIH,

2;

G. S. Firestein,

NIH,

2.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ikk%ce%b5-deficiency-prolongs-neutrophil-survival-paradoxically-prolonging-inflammation-in-the-absence-of-a-type-i-interferon-response/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology